인도의 체외수정(IVF) 서비스 시장은 2025-2032년의 예측 기간 동안 13.51%의 연평균 복합 성장률(CAGR)을 기록할 것으로 추정됩니다. 2024년 17억 4,000만 달러에서 2032년에는 48억 달러로 성장할 것으로 예상됩니다.
체외수정(IVF) 서비스의 인도 시장은 최근 체외수정(IVF) 기술의 발전과 효율적인 솔루션에 대한 수요가 증가함에 따라 크게 성장하고 있습니다. 이 나라 시장 확대를 뒷받침하는 주요 요인 중 하나는 앉아있는 라이프 스타일과 환경 조건의 변화로 인해 많은 국민들이 생식 기능을 저하시키고 있다는 것입니다. 대부분의 사람들은 특히 이러한 중요하고 인생을 바꾸는 치료와 관련하여 건강과 행복을 위해 사용하는 여분의 돈을 가지고 있습니다. 또한 시장 성장 궤도는 의료 인프라에 대한 정부 투자, 기술 진보 및 최첨단 솔루션에 대한 수요가 증가함에 따라 강화되고 있습니다. 특히 아시아태평양의 건강 관리의 급속한 진보는 유리한 전망을 가져옵니다. 예를 들어, CK Birla Healthcare Pvt.Ltd.는 2024년 1월 우타르 프라데시 주 미루트에 다양한 불임 문제에 대응하는 새로운 불임 치료 클리닉을 도입했습니다.
모든 부문은 해당 지역 및 국가에서 제공됩니다.
위의 회사는 시장 점유율을 기반으로 주문을 보류하지 않았으며 조사 작업 중에 사용 가능한 정보를 기반으로 변경될 수 있습니다.
India in-vitro fertilization services market is projected to witness a CAGR of 13.51% during the forecast period FY2025-FY2032, growing from USD 1.74 billion in FY2024 to USD 4.80 billion in FY2032.
Indian market for in-vitro fertilization services has grown significantly owing to the recent advancements in IVF techniques and the growing demand for efficient solutions. One of the primary elements propelling market expansions in the country is most of the population's declining reproductive health due to sedentary lifestyles and shifting environmental conditions. Most people have extra money to spend on their health and well-being, particularly concerning such important and life-changing procedures. Furthermore, the market's growth trajectory is being reinforced by government investments in healthcare infrastructure, technological progression, and the growing demand for cutting-edge solutions. Rapid advancements in healthcare, particularly in Asia-Pacific, present lucrative prospects. For example, CK Birla Healthcare Pvt. Ltd. introduced a new fertility clinic in Meerut, Uttar Pradesh in January 2024 that caters to various fertility issues.
Advancements in Technology Boost India In-Vitro Fertilization Services Market Growth
The in-vitro fertilization (IVF) industry is growing rapidly in India on the backdrop of advancements in technology that have increased treatment effectiveness and success rates. Advances such as time-lapse imaging, preimplantation genetic testing (PGT), and embryo vitrification have improved implantation rates and reduced miscarriage risks, making IVF a more reliable option for infertile couples in recent years. These technological developments have increased patient confidence and expanded the patient pool to include individuals with genetic issues or age-related infertility.
Automation and artificial intelligence (AI), which reduce human error and maximize embryo selection, further revolutionize IVF. The enhanced ability of AI-driven models to accurately evaluate embryo viability increases pregnancy success rates. Additionally, cryopreservation methods, such as freezing oocytes and embryos, allow patients to save their fertility for later use, increasing the demand for IVF services. Due to these advancements, rising awareness, and greater funding in reproductive clinics, IVF procedures are now more accessible and affordable. As success rates increase, IVF is becoming widely popular among individuals and couples, including LGBTQ+ individuals and single parents, which is driving the market's expansion. Thus, IVF technology developments are key to the market's consistent growth. For instance, the government of Goa launched the Intrauterine Insemination /In-Vitro Fertilization and Assisted Reproductive Technology Center in August 2023 at the Goa Medical College and Hospital (GMC). The center provides free infertility treatment.
Rising Awareness and Acceptance Fuel the Market Growth
The expansion of India's fertility business has been greatly aided by the increasing awareness and public acceptance of in-vitro fertilization (IVF). Infertility was once a taboo topic, but because of healthcare initiatives, media influence, and education, there is now more openness and acceptance of IVF procedures. Due to better access to information through digital platforms and healthcare campaigns, couples who are having trouble conceiving are now more likely to look for medical options.
Furthermore, IVF is now more widely available due to the growth of fertility clinics in Tier 2 and Tier 3 cities, affordable treatment choices, and government initiatives. The industry has grown owing to shifting attitudes, the acceptance of IVF among LGBTQ+ people and single parents, and corporate insurance coverage for fertility treatments. For instance, Nova IVF introduced "Fertility Tales," a podcast project in November 2023, to raise awareness about fertility treatment through engaging narratives. The podcast interviews industry stakeholders and shares real patient stories about firsthand experiences with IVF treatment.
Rising Infrastructure Drive India In-Vitro Fertilization Services Market Growth
The in-vitro fertilization (IVF) market has grown tremendously due to India's rapidly developing healthcare infrastructure. Fertility treatments are now more widely available due to the construction of specialized fertility centers, cutting-edge reproductive laboratories, and enhanced hospital facilities throughout metropolitan and semi-urban areas. Prominent healthcare organizations such as Apollo, Fortis, and Nova IVF Fertility have extended their IVF offerings by incorporating state-of-the-art technology such as genetic testing, sophisticated cryopreservation, and AI-based embryo selection.
Infrastructure development is tremendously accelerated by government efforts such as Public-Private Partnerships (PPP) and greater foreign investments. Furthermore, the growth of medical tourism has drawn people from all over the world due to India's high-quality fertility therapies and affordability. IVF adoption is also fueled by improved healthcare accessibility and connection in tier-2 and tier-3 cities. With continuous investments in healthcare infrastructure and innovation, India's IVF market is set for exponential growth, catering to rising infertility rates and evolving patient needs.
For example, in February 2024, Sabine Hospital, an IVF hospital based in Kerala, announced the installation of a Next Generation Sequencer (NGS), to detect genetic diseases in the developing fetus while the fetus is still in the womb.
Future Market Scenario (FY2025 - FY2032F)
Many factors claim the growth of India in-vitro fertilization service market. Technological advancements give faster and more accurate results leading us to early diagnosis. Opportunity also lies in the increasing fertility concerns the population faces today. Promising initiatives of our government that provide healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone is testimonial.
For instance, in December 2023, Little Angel IVF launched in-vitro fertilization treatments such as personalized fertility consultation, comprehensive diagnostic services, advanced IVF treatments, and intracytoplasmic sperm injection (ICSI) for Non-Resident Indian patients.
Key Players Landscape and Outlook
Key players in the in-vitro fertilization services industry utilize mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.
For instance, in June 2023, Nova Pulse IVF Clinic Private Limited acquired WINGS IVF, a regional IVF chain based in Ahmedabad. This acquisition expands Nova IVF Fertility's reach to 68 centers in 44 cities.
In March 2023, Santaan Fertility Center & Research Institute Private Limited launched a new fertility clinic and research institute in Odisha, India, and Indira IVF opened its 116th IVF center in Pune, Maharashtra, an addition to the existing center in Pune.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.